1. Home
  2. LQDT vs TBPH Comparison

LQDT vs TBPH Comparison

Compare LQDT & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

HOLD

Current Price

$35.31

Market Cap

985.8M

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.79

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDT
TBPH
Founded
1999
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
985.8M
824.9M
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
LQDT
TBPH
Price
$35.31
$16.79
Analyst Decision
Buy
Buy
Analyst Count
1
6
Target Price
$40.00
$18.40
AVG Volume (30 Days)
134.2K
414.8K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
38.10
279.13
EPS
0.23
2.06
Revenue
$476,669,000.00
$15,386,000.00
Revenue This Year
N/A
$8.46
Revenue Next Year
N/A
N/A
P/E Ratio
$151.17
$7.97
Revenue Growth
31.20
N/A
52 Week Low
$21.67
$8.33
52 Week High
$35.16
$21.03

Technical Indicators

Market Signals
Indicator
LQDT
TBPH
Relative Strength Index (RSI) 77.21 57.45
Support Level $30.51 $13.41
Resistance Level N/A $17.24
Average True Range (ATR) 0.84 0.41
MACD 0.23 0.02
Stochastic Oscillator 91.45 59.28

Price Performance

Historical Comparison
LQDT
TBPH

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: